CLINICAL TRIALS

Dr. Andrew Reynolds - Pediatrics

A Phase 3/4, Prospective, Randomized, Active Treatment-Controlled, Parallel-Design, Multicenter Study to Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract.

Enrolling children from birth through age 3 with non-acquired/congenital cataracts.

Learn More: https://clinicaltrials.gov/ct2/show/NCT05191706

Dr. Weiner

Baerveldt 350mm vs. Clear Path 250 mm: recruiting for this study comparing two glaucoma drainage devices.

DECLARE- Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE), seeking enrollment of 25 patients.

Learn More: https://clinicaltrials.gov/ct2/show/NCT04542616

Dr. Sieminiski

A prospective, randomized, multi-center evaluation of the Safety and Effectiveness of the STREAMLINE®SURGICAL SYSTEM compared to iStent Inject W® in Patients with Open-Angle Glaucoma: seeking enrollment of patients with mild-moderate glaucoma undergoing cataract surgery.

Learn More: https://clinicaltrials.gov/ct2/show/NCT05280366

Call 716-881-7900 Or Make An Appointment Online Here.